Literature DB >> 30796073

Unknown primary Merkel cell carcinoma with cutaneous spread.

João Vasco Barreira1, Margarida Moura Valejo Coelho2, Catarina Ribeiro3, Mónica Semedo4.   

Abstract

The authors present the case of a woman in the seventh decade of life with medical history of: left nephrectomy for renal tuberculosis and non-Hodgkin's lymphoma treated with chemotherapy (QT) and radiotherapy. She presented with a 2-month history of non-tender, left inguinal lymph node enlargement. Positron Emission Tomography (PET)-CT -scanshowed hypermetabolic inguinal and retroperitoneal lymphadenopathies, no primary tumour. On the second dermatological examination a pink, 2 cm plaque on the anterior left knee was noted. The histopathological analysis revealed Merkel cell carcinoma. The patient underwent two lines of systemic QT, with life-threatening toxicities limiting treatment. Followed overwhelming disease progression with lymphoedema and numerous skin metastases in the left lower limb. The patient received palliative care until death. The rare incidence of such neoplasia and its uncommon clinical presentation justifies reporting this case and highlights the importance of multidisciplinary teams in the management of cancer patients. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  dermatology; oncology; skin cancer

Mesh:

Year:  2019        PMID: 30796073      PMCID: PMC6388886          DOI: 10.1136/bcr-2018-224834

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

Review 1.  Immunobiology of Merkel cell carcinoma: implications for immunotherapy of a polyomavirus-associated cancer.

Authors:  Shailender Bhatia; Olga Afanasiev; Paul Nghiem
Journal:  Curr Oncol Rep       Date:  2011-12       Impact factor: 5.075

2.  Merkel cell carcinoma of unknown primary origin.

Authors:  Jeremiah L Deneve; Jane L Messina; Suroosh S Marzban; Ricardo J Gonzalez; Brooke M Walls; Kate J Fisher; Y Ann Chen; C Wayne Cruse; Vernon K Sondak; Jonathan S Zager
Journal:  Ann Surg Oncol       Date:  2012-01-21       Impact factor: 5.344

3.  A better prognosis for Merkel cell carcinoma of unknown primary origin.

Authors:  Kathryn T Chen; Pavlos Papavasiliou; Kyle Edwards; Fang Zhu; Clifford Perlis; Hong Wu; Aruna Turaka; Adam Berger; Jeffrey M Farma
Journal:  Am J Surg       Date:  2013-07-05       Impact factor: 2.565

4.  Management of Merkel cell carcinoma of unknown primary origin: the Vienna Medical School experience.

Authors:  Georg Haymerle; Alexandra Fochtmann; Rainer Kunstfeld; Johannes Pammer; Boban M Erovic
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-03-15       Impact factor: 2.503

5.  Durable Tumor Regression and Overall Survival in Patients With Advanced Merkel Cell Carcinoma Receiving Pembrolizumab as First-Line Therapy.

Authors:  Paul Nghiem; Shailender Bhatia; Evan J Lipson; William H Sharfman; Ragini R Kudchadkar; Andrew S Brohl; Phillip A Friedlander; Adil Daud; Harriet M Kluger; Sunil A Reddy; Brian C Boulmay; Adam I Riker; Melissa A Burgess; Brent A Hanks; Thomas Olencki; Kim Margolin; Lisa M Lundgren; Abha Soni; Nirasha Ramchurren; Candice Church; Song Y Park; Michi M Shinohara; Bob Salim; Janis M Taube; Steven R Bird; Nageatte Ibrahim; Steven P Fling; Blanca Homet Moreno; Elad Sharon; Martin A Cheever; Suzanne L Topalian
Journal:  J Clin Oncol       Date:  2019-02-06       Impact factor: 44.544

6.  Clonal integration of a polyomavirus in human Merkel cell carcinoma.

Authors:  Huichen Feng; Masahiro Shuda; Yuan Chang; Patrick S Moore
Journal:  Science       Date:  2008-01-17       Impact factor: 47.728

7.  New developments in the biology and the treatment of metastatic Merkel cell carcinoma.

Authors:  Patrick Terheyden; Jürgen C Becker
Journal:  Curr Opin Oncol       Date:  2017-05       Impact factor: 3.645

8.  Metastatic Merkel-cell carcinoma: the dawn of a new era.

Authors:  Timothy O'Brien; Derek G Power
Journal:  BMJ Case Rep       Date:  2018-07-11

Review 9.  Unknown primary Merkel cell carcinoma: 23 new cases and a review.

Authors:  Tina I Tarantola; Laura A Vallow; Michele Y Halyard; Roger H Weenig; Karen E Warschaw; Amy L Weaver; Randall K Roenigk; Jerry D Brewer; Clark C Otley
Journal:  J Am Acad Dermatol       Date:  2012-11-19       Impact factor: 11.527

Review 10.  Systematic literature review of efficacy, safety and tolerability outcomes of chemotherapy regimens in patients with metastatic Merkel cell carcinoma.

Authors:  Paul Nghiem; Howard L Kaufman; Murtuza Bharmal; Lisa Mahnke; Hemant Phatak; Jürgen C Becker
Journal:  Future Oncol       Date:  2017-03-28       Impact factor: 3.404

View more
  2 in total

1.  Nationwide multidisciplinary consensus on the clinical management of Merkel cell carcinoma: a Delphi panel.

Authors:  Francesca Spada; Paolo Bossi; Corrado Caracò; Vanna Chiarion Sileni; Angelo Paolo Dei Tos; Nicola Fazio; Giovanni Grignani; Michele Maio; Pietro Quaglino; Paola Queirolo; Paolo Antonio Ascierto
Journal:  J Immunother Cancer       Date:  2022-06       Impact factor: 12.469

2.  Volumetric Modulated Arc Therapy Capabilities for Treating Lower-Extremity Skin Affected by Several Merkel Cell Carcinoma Nodules: When Technological Advances Effectively Achieve the Palliative Therapeutic Goal while Minimising the Risk of Potential Toxicities.

Authors:  Gianluca Ferini; Vito Valenti; Ivana Puliafito; Salvatore Ivan Illari; Valentina Anna Marchese; Giuseppina Rita Borzì
Journal:  Medicina (Kaunas)       Date:  2021-12-18       Impact factor: 2.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.